nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—Nucleic Acid Synthesis Inhibitors—Capecitabine—prostate cancer	0.781	1	CiPCiCtD
Nelarabine—DGUOK—prostate gland—prostate cancer	0.00406	0.101	CbGeAlD
Nelarabine—DGUOK—seminal vesicle—prostate cancer	0.00343	0.0851	CbGeAlD
Nelarabine—DGUOK—renal system—prostate cancer	0.00277	0.0685	CbGeAlD
Nelarabine—DGUOK—urethra—prostate cancer	0.00272	0.0673	CbGeAlD
Nelarabine—POLA1—prostate gland—prostate cancer	0.0025	0.062	CbGeAlD
Nelarabine—ADA—prostate gland—prostate cancer	0.00232	0.0575	CbGeAlD
Nelarabine—POLA1—seminal vesicle—prostate cancer	0.00212	0.0525	CbGeAlD
Nelarabine—DGUOK—bone marrow—prostate cancer	0.00209	0.0518	CbGeAlD
Nelarabine—DGUOK—testis—prostate cancer	0.00179	0.0443	CbGeAlD
Nelarabine—POLA1—urethra—prostate cancer	0.00168	0.0415	CbGeAlD
Nelarabine—ADA—renal system—prostate cancer	0.00158	0.0392	CbGeAlD
Nelarabine—DCK—prostate gland—prostate cancer	0.00154	0.0382	CbGeAlD
Nelarabine—DCK—seminal vesicle—prostate cancer	0.00131	0.0323	CbGeAlD
Nelarabine—DGUOK—lymph node—prostate cancer	0.0013	0.0321	CbGeAlD
Nelarabine—POLA1—bone marrow—prostate cancer	0.00129	0.032	CbGeAlD
Nelarabine—ADA—bone marrow—prostate cancer	0.0012	0.0297	CbGeAlD
Nelarabine—POLA1—testis—prostate cancer	0.0011	0.0273	CbGeAlD
Nelarabine—DCK—urethra—prostate cancer	0.00103	0.0256	CbGeAlD
Nelarabine—ADA—testis—prostate cancer	0.00102	0.0253	CbGeAlD
Nelarabine—POLA1—lymph node—prostate cancer	0.0008	0.0198	CbGeAlD
Nelarabine—DCK—bone marrow—prostate cancer	0.000796	0.0197	CbGeAlD
Nelarabine—ADA—lymph node—prostate cancer	0.000742	0.0184	CbGeAlD
Nelarabine—S-Adenosylmethionine—GNMT—prostate cancer	0.000718	0.234	CrCbGaD
Nelarabine—DCK—testis—prostate cancer	0.00068	0.0168	CbGeAlD
Nelarabine—DCK—lymph node—prostate cancer	0.000493	0.0122	CbGeAlD
Nelarabine—Azacitidine—DNMT1—prostate cancer	0.000456	0.149	CrCbGaD
Nelarabine—Decitabine—DNMT1—prostate cancer	0.000445	0.145	CrCbGaD
Nelarabine—Adenosine triphosphate—HSPA1A—prostate cancer	0.000406	0.132	CrCbGaD
Nelarabine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.000344	0.139	CbGdCrCtD
Nelarabine—DCK—Fulvestrant—Estradiol—prostate cancer	0.000279	0.112	CbGdCrCtD
Nelarabine—POLA1—Norethindrone—Ethinyl Estradiol—prostate cancer	0.000266	0.107	CbGdCrCtD
Nelarabine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.000261	0.105	CbGdCrCtD
Nelarabine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.000255	0.103	CbGdCrCtD
Nelarabine—DCK—Levorphanol—Estrone—prostate cancer	0.000243	0.098	CbGdCrCtD
Nelarabine—POLA1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000211	0.0853	CbGdCrCtD
Nelarabine—S-Adenosylmethionine—COMT—prostate cancer	0.000184	0.0601	CrCbGaD
Nelarabine—DCK—Levorphanol—Estradiol—prostate cancer	0.000184	0.0742	CbGdCrCtD
Nelarabine—Adenosine monophosphate—PDE4D—prostate cancer	0.000179	0.0585	CrCbGaD
Nelarabine—Adenosine triphosphate—AKT1—prostate cancer	0.000159	0.0519	CrCbGaD
Nelarabine—Adenosine monophosphate—SRC—prostate cancer	0.000157	0.0511	CrCbGaD
Nelarabine—DCK—Doxorubicin—Epirubicin—prostate cancer	0.000128	0.0516	CbGdCrCtD
Nelarabine—Cytarabine—SLC22A1—prostate cancer	0.000122	0.0398	CrCbGaD
Nelarabine—DCK—Epirubicin—Doxorubicin—prostate cancer	0.000118	0.0477	CbGdCrCtD
Nelarabine—Cladribine—SLC22A1—prostate cancer	0.000112	0.0366	CrCbGaD
Nelarabine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	8.72e-05	0.0352	CbGdCrCtD
Nelarabine—S-Adenosylmethionine—CYP2E1—prostate cancer	8.58e-05	0.028	CrCbGaD
Nelarabine—DCK—Desoximetasone—Prednisone—prostate cancer	5.24e-05	0.0211	CbGdCrCtD
Nelarabine—DCK—Diflorasone—Prednisone—prostate cancer	5.08e-05	0.0205	CbGdCrCtD
Nelarabine—ADA—Metabolism—TNFRSF21—prostate cancer	4.66e-05	0.000887	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—HIST1H2BG—prostate cancer	4.63e-05	0.000883	CbGpPWpGaD
Nelarabine—POLA1—DNA Replication—CDKN1A—prostate cancer	4.59e-05	0.000874	CbGpPWpGaD
Nelarabine—DCK—Metabolism—B4GALT4—prostate cancer	4.57e-05	0.000871	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HPGD—prostate cancer	4.57e-05	0.000871	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—prostate cancer	4.54e-05	0.000864	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTAP—prostate cancer	4.53e-05	0.000863	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP7B1—prostate cancer	4.53e-05	0.000863	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP1A1—prostate cancer	4.5e-05	0.000858	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—prostate cancer	4.5e-05	0.000857	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—HIST1H4H—prostate cancer	4.48e-05	0.000852	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ERCC2—prostate cancer	4.47e-05	0.000851	CbGpPWpGaD
Nelarabine—POLA1—G1/S Transition—CDKN1A—prostate cancer	4.42e-05	0.000842	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SULT1E1—prostate cancer	4.42e-05	0.000841	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SRD5A1—prostate cancer	4.42e-05	0.000841	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—prostate cancer	4.39e-05	0.000837	CbGpPWpGaD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—prostate cancer	4.39e-05	0.000836	CbGpPWpGaD
Nelarabine—POLA1—S Phase—CDKN1B—prostate cancer	4.35e-05	0.000829	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TNFRSF21—prostate cancer	4.3e-05	0.000819	CbGpPWpGaD
Nelarabine—Hypotension—Etoposide—prostate cancer	4.28e-05	0.000356	CcSEcCtD
Nelarabine—Cytarabine—CYP3A4—prostate cancer	4.26e-05	0.0139	CrCbGaD
Nelarabine—Muscular weakness—Doxorubicin—prostate cancer	4.26e-05	0.000355	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—prostate cancer	4.25e-05	0.00081	CbGpPWpGaD
Nelarabine—Vision blurred—Capecitabine—prostate cancer	4.25e-05	0.000354	CcSEcCtD
Nelarabine—Asthenia—Estradiol—prostate cancer	4.24e-05	0.000353	CcSEcCtD
Nelarabine—Tremor—Capecitabine—prostate cancer	4.23e-05	0.000352	CcSEcCtD
Nelarabine—Neutropenia—Epirubicin—prostate cancer	4.22e-05	0.000351	CcSEcCtD
Nelarabine—ADA—Metabolism—ACSL4—prostate cancer	4.21e-05	0.000803	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD17B3—prostate cancer	4.21e-05	0.000803	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MAD1L1—prostate cancer	4.21e-05	0.000801	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—prostate cancer	4.21e-05	0.000801	CbGpPWpGaD
Nelarabine—Abdominal distension—Doxorubicin—prostate cancer	4.2e-05	0.00035	CcSEcCtD
Nelarabine—DGUOK—Metabolism—MTHFR—prostate cancer	4.2e-05	0.0008	CbGpPWpGaD
Nelarabine—Angiopathy—Prednisone—prostate cancer	4.19e-05	0.000349	CcSEcCtD
Nelarabine—DCK—Metabolism—MTAP—prostate cancer	4.18e-05	0.000797	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP7B1—prostate cancer	4.18e-05	0.000797	CbGpPWpGaD
Nelarabine—Leukopenia—Docetaxel—prostate cancer	4.17e-05	0.000347	CcSEcCtD
Nelarabine—Anaemia—Capecitabine—prostate cancer	4.17e-05	0.000347	CcSEcCtD
Nelarabine—POLA1—S Phase—CCND1—prostate cancer	4.15e-05	0.00079	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARA—prostate cancer	4.12e-05	0.000785	CbGpPWpGaD
Nelarabine—Paraesthesia—Etoposide—prostate cancer	4.11e-05	0.000342	CcSEcCtD
Nelarabine—Loss of consciousness—Docetaxel—prostate cancer	4.1e-05	0.000341	CcSEcCtD
Nelarabine—Dyspnoea—Etoposide—prostate cancer	4.08e-05	0.00034	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—TOP2A—prostate cancer	4.08e-05	0.000777	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SULT1E1—prostate cancer	4.08e-05	0.000776	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SRD5A1—prostate cancer	4.08e-05	0.000776	CbGpPWpGaD
Nelarabine—Hyperglycaemia—Epirubicin—prostate cancer	4.07e-05	0.000339	CcSEcCtD
Nelarabine—Somnolence—Etoposide—prostate cancer	4.07e-05	0.000339	CcSEcCtD
Nelarabine—Cough—Docetaxel—prostate cancer	4.07e-05	0.000339	CcSEcCtD
Nelarabine—Pneumonia—Epirubicin—prostate cancer	4.05e-05	0.000337	CcSEcCtD
Nelarabine—Mental disorder—Prednisone—prostate cancer	4.05e-05	0.000337	CcSEcCtD
Nelarabine—Diarrhoea—Estradiol—prostate cancer	4.04e-05	0.000336	CcSEcCtD
Nelarabine—Leukopenia—Capecitabine—prostate cancer	4.04e-05	0.000336	CcSEcCtD
Nelarabine—ADA—Metabolism—PHGDH—prostate cancer	4.04e-05	0.000769	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UMPS—prostate cancer	4.04e-05	0.000769	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ARG2—prostate cancer	4.04e-05	0.000769	CbGpPWpGaD
Nelarabine—Convulsion—Docetaxel—prostate cancer	4.04e-05	0.000336	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—prostate cancer	4.04e-05	0.000769	CbGpPWpGaD
Nelarabine—Infestation—Epirubicin—prostate cancer	4.02e-05	0.000335	CcSEcCtD
Nelarabine—Infestation NOS—Epirubicin—prostate cancer	4.02e-05	0.000335	CcSEcCtD
Nelarabine—Malnutrition—Prednisone—prostate cancer	4.02e-05	0.000335	CcSEcCtD
Nelarabine—POLA1—S Phase—CDKN1A—prostate cancer	4.01e-05	0.000765	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—PTEN—prostate cancer	4e-05	0.000762	CbGpPWpGaD
Nelarabine—Decreased appetite—Etoposide—prostate cancer	3.98e-05	0.000331	CcSEcCtD
Nelarabine—Chest pain—Docetaxel—prostate cancer	3.97e-05	0.00033	CcSEcCtD
Nelarabine—Myalgia—Docetaxel—prostate cancer	3.97e-05	0.00033	CcSEcCtD
Nelarabine—Arthralgia—Docetaxel—prostate cancer	3.97e-05	0.00033	CcSEcCtD
Nelarabine—Loss of consciousness—Capecitabine—prostate cancer	3.97e-05	0.00033	CcSEcCtD
Nelarabine—ADA—Metabolism—LDHB—prostate cancer	3.96e-05	0.000755	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Etoposide—prostate cancer	3.95e-05	0.000329	CcSEcCtD
Nelarabine—Asthenia—Mitoxantrone—prostate cancer	3.95e-05	0.000329	CcSEcCtD
Nelarabine—Fatigue—Etoposide—prostate cancer	3.95e-05	0.000329	CcSEcCtD
Nelarabine—Neuropathy peripheral—Epirubicin—prostate cancer	3.94e-05	0.000328	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CREBBP—prostate cancer	3.94e-05	0.000751	CbGpPWpGaD
Nelarabine—Cough—Capecitabine—prostate cancer	3.94e-05	0.000328	CcSEcCtD
Nelarabine—Stomatitis—Epirubicin—prostate cancer	3.92e-05	0.000326	CcSEcCtD
Nelarabine—Constipation—Etoposide—prostate cancer	3.92e-05	0.000326	CcSEcCtD
Nelarabine—Pain—Etoposide—prostate cancer	3.92e-05	0.000326	CcSEcCtD
Nelarabine—Dizziness—Estradiol—prostate cancer	3.91e-05	0.000325	CcSEcCtD
Nelarabine—Neutropenia—Doxorubicin—prostate cancer	3.9e-05	0.000325	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—prostate cancer	3.9e-05	0.000742	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—AURKA—prostate cancer	3.89e-05	0.000741	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD17B3—prostate cancer	3.89e-05	0.000741	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP3A5—prostate cancer	3.89e-05	0.000741	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACSL4—prostate cancer	3.89e-05	0.000741	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CAV1—prostate cancer	3.87e-05	0.000738	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—NBN—prostate cancer	3.87e-05	0.000737	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CCND1—prostate cancer	3.85e-05	0.000734	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MLH1—prostate cancer	3.85e-05	0.000733	CbGpPWpGaD
Nelarabine—Chest pain—Capecitabine—prostate cancer	3.84e-05	0.00032	CcSEcCtD
Nelarabine—Myalgia—Capecitabine—prostate cancer	3.84e-05	0.00032	CcSEcCtD
Nelarabine—Arthralgia—Capecitabine—prostate cancer	3.84e-05	0.00032	CcSEcCtD
Nelarabine—Confusional state—Docetaxel—prostate cancer	3.84e-05	0.000319	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—EP300—prostate cancer	3.82e-05	0.000727	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Epirubicin—prostate cancer	3.81e-05	0.000317	CcSEcCtD
Nelarabine—Oedema—Docetaxel—prostate cancer	3.81e-05	0.000317	CcSEcCtD
Nelarabine—Epistaxis—Epirubicin—prostate cancer	3.8e-05	0.000316	CcSEcCtD
Nelarabine—Vision blurred—Prednisone—prostate cancer	3.79e-05	0.000315	CcSEcCtD
Nelarabine—Infection—Docetaxel—prostate cancer	3.78e-05	0.000315	CcSEcCtD
Nelarabine—Sinusitis—Epirubicin—prostate cancer	3.78e-05	0.000314	CcSEcCtD
Nelarabine—Feeling abnormal—Etoposide—prostate cancer	3.77e-05	0.000314	CcSEcCtD
Nelarabine—Hyperglycaemia—Doxorubicin—prostate cancer	3.77e-05	0.000314	CcSEcCtD
Nelarabine—Diarrhoea—Mitoxantrone—prostate cancer	3.77e-05	0.000313	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAP2K1—prostate cancer	3.76e-05	0.000717	CbGpPWpGaD
Nelarabine—Vomiting—Estradiol—prostate cancer	3.76e-05	0.000313	CcSEcCtD
Nelarabine—ADA—Metabolism—PDHA1—prostate cancer	3.76e-05	0.000715	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TCN2—prostate cancer	3.76e-05	0.000715	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA3—prostate cancer	3.76e-05	0.000715	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UCP3—prostate cancer	3.76e-05	0.000715	CbGpPWpGaD
Nelarabine—Pneumonia—Doxorubicin—prostate cancer	3.75e-05	0.000312	CcSEcCtD
Nelarabine—Gastrointestinal pain—Etoposide—prostate cancer	3.74e-05	0.000312	CcSEcCtD
Nelarabine—Nervous system disorder—Docetaxel—prostate cancer	3.73e-05	0.000311	CcSEcCtD
Nelarabine—DCK—Metabolism—PHGDH—prostate cancer	3.73e-05	0.00071	CbGpPWpGaD
Nelarabine—DCK—Metabolism—UMPS—prostate cancer	3.73e-05	0.00071	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ARG2—prostate cancer	3.73e-05	0.00071	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—prostate cancer	3.73e-05	0.00071	CbGpPWpGaD
Nelarabine—Thrombocytopenia—Docetaxel—prostate cancer	3.73e-05	0.00031	CcSEcCtD
Nelarabine—Infestation—Doxorubicin—prostate cancer	3.72e-05	0.00031	CcSEcCtD
Nelarabine—Infestation NOS—Doxorubicin—prostate cancer	3.72e-05	0.00031	CcSEcCtD
Nelarabine—Anaemia—Prednisone—prostate cancer	3.72e-05	0.000309	CcSEcCtD
Nelarabine—Confusional state—Capecitabine—prostate cancer	3.71e-05	0.000309	CcSEcCtD
Nelarabine—Headache—Estradiol—prostate cancer	3.7e-05	0.000308	CcSEcCtD
Nelarabine—Oedema—Capecitabine—prostate cancer	3.68e-05	0.000307	CcSEcCtD
Nelarabine—POLA1—G1/S Transition—MYC—prostate cancer	3.67e-05	0.000698	CbGpPWpGaD
Nelarabine—Infection—Capecitabine—prostate cancer	3.66e-05	0.000305	CcSEcCtD
Nelarabine—DCK—Metabolism—LDHB—prostate cancer	3.66e-05	0.000696	CbGpPWpGaD
Nelarabine—Neuropathy peripheral—Doxorubicin—prostate cancer	3.65e-05	0.000304	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—TOP2A—prostate cancer	3.65e-05	0.000695	CbGpPWpGaD
Nelarabine—Stomatitis—Doxorubicin—prostate cancer	3.63e-05	0.000302	CcSEcCtD
Nelarabine—Anorexia—Docetaxel—prostate cancer	3.63e-05	0.000302	CcSEcCtD
Nelarabine—Body temperature increased—Etoposide—prostate cancer	3.62e-05	0.000301	CcSEcCtD
Nelarabine—Abdominal pain—Etoposide—prostate cancer	3.62e-05	0.000301	CcSEcCtD
Nelarabine—Nervous system disorder—Capecitabine—prostate cancer	3.61e-05	0.000301	CcSEcCtD
Nelarabine—Thrombocytopenia—Capecitabine—prostate cancer	3.61e-05	0.0003	CcSEcCtD
Nelarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—prostate cancer	3.61e-05	0.000687	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Epirubicin—prostate cancer	3.59e-05	0.000299	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP3A5—prostate cancer	3.59e-05	0.000684	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD3B1—prostate cancer	3.58e-05	0.000682	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC22A3—prostate cancer	3.58e-05	0.000682	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—prostate cancer	3.58e-05	0.000682	CbGpPWpGaD
Nelarabine—Urinary tract disorder—Epirubicin—prostate cancer	3.57e-05	0.000297	CcSEcCtD
Nelarabine—Oedema peripheral—Epirubicin—prostate cancer	3.56e-05	0.000296	CcSEcCtD
Nelarabine—Hypotension—Docetaxel—prostate cancer	3.56e-05	0.000296	CcSEcCtD
Nelarabine—Connective tissue disorder—Epirubicin—prostate cancer	3.55e-05	0.000295	CcSEcCtD
Nelarabine—Urethral disorder—Epirubicin—prostate cancer	3.54e-05	0.000295	CcSEcCtD
Nelarabine—Loss of consciousness—Prednisone—prostate cancer	3.53e-05	0.000294	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CG—prostate cancer	3.53e-05	0.000672	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Doxorubicin—prostate cancer	3.52e-05	0.000293	CcSEcCtD
Nelarabine—Epistaxis—Doxorubicin—prostate cancer	3.51e-05	0.000292	CcSEcCtD
Nelarabine—Anorexia—Capecitabine—prostate cancer	3.51e-05	0.000292	CcSEcCtD
Nelarabine—Nausea—Estradiol—prostate cancer	3.51e-05	0.000292	CcSEcCtD
Nelarabine—Vomiting—Mitoxantrone—prostate cancer	3.5e-05	0.000291	CcSEcCtD
Nelarabine—Sinusitis—Doxorubicin—prostate cancer	3.49e-05	0.000291	CcSEcCtD
Nelarabine—Convulsion—Prednisone—prostate cancer	3.48e-05	0.00029	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—AURKA—prostate cancer	3.48e-05	0.000663	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.47e-05	0.000289	CcSEcCtD
Nelarabine—DCK—Metabolism—PDHA1—prostate cancer	3.47e-05	0.00066	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TCN2—prostate cancer	3.47e-05	0.00066	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA3—prostate cancer	3.47e-05	0.00066	CbGpPWpGaD
Nelarabine—DCK—Metabolism—UCP3—prostate cancer	3.47e-05	0.00066	CbGpPWpGaD
Nelarabine—Headache—Mitoxantrone—prostate cancer	3.45e-05	0.000287	CcSEcCtD
Nelarabine—Hypotension—Capecitabine—prostate cancer	3.44e-05	0.000287	CcSEcCtD
Nelarabine—Insomnia—Docetaxel—prostate cancer	3.44e-05	0.000286	CcSEcCtD
Nelarabine—ADA—Metabolism—TBXAS1—prostate cancer	3.44e-05	0.000654	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA4—prostate cancer	3.44e-05	0.000654	CbGpPWpGaD
Nelarabine—Myalgia—Prednisone—prostate cancer	3.42e-05	0.000285	CcSEcCtD
Nelarabine—Arthralgia—Prednisone—prostate cancer	3.42e-05	0.000285	CcSEcCtD
Nelarabine—Paraesthesia—Docetaxel—prostate cancer	3.42e-05	0.000284	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	3.4e-05	0.000648	CbGpPWpGaD
Nelarabine—Dyspnoea—Docetaxel—prostate cancer	3.39e-05	0.000282	CcSEcCtD
Nelarabine—Somnolence—Docetaxel—prostate cancer	3.38e-05	0.000282	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—APEX1—prostate cancer	3.38e-05	0.000644	CbGpPWpGaD
Nelarabine—Eye disorder—Epirubicin—prostate cancer	3.38e-05	0.000281	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.36e-05	0.000279	CcSEcCtD
Nelarabine—Cardiac disorder—Epirubicin—prostate cancer	3.35e-05	0.000279	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	3.35e-05	0.000638	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA2—prostate cancer	3.35e-05	0.000638	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—INS—prostate cancer	3.34e-05	0.000636	CbGpPWpGaD
Nelarabine—Insomnia—Capecitabine—prostate cancer	3.33e-05	0.000277	CcSEcCtD
Nelarabine—POLA1—S Phase—MYC—prostate cancer	3.33e-05	0.000634	CbGpPWpGaD
Nelarabine—Hypoaesthesia—Doxorubicin—prostate cancer	3.33e-05	0.000277	CcSEcCtD
Nelarabine—Paraesthesia—Capecitabine—prostate cancer	3.31e-05	0.000275	CcSEcCtD
Nelarabine—Decreased appetite—Docetaxel—prostate cancer	3.31e-05	0.000275	CcSEcCtD
Nelarabine—DCK—Metabolism—HSD3B1—prostate cancer	3.31e-05	0.00063	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC22A3—prostate cancer	3.31e-05	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SULT1A1—prostate cancer	3.31e-05	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCG5—prostate cancer	3.31e-05	0.00063	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	3.3e-05	0.000629	CbGpPWpGaD
Nelarabine—Urinary tract disorder—Doxorubicin—prostate cancer	3.3e-05	0.000275	CcSEcCtD
Nelarabine—Oedema peripheral—Doxorubicin—prostate cancer	3.29e-05	0.000274	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.29e-05	0.000273	CcSEcCtD
Nelarabine—Asthenia—Etoposide—prostate cancer	3.29e-05	0.000273	CcSEcCtD
Nelarabine—Connective tissue disorder—Doxorubicin—prostate cancer	3.28e-05	0.000273	CcSEcCtD
Nelarabine—Dyspnoea—Capecitabine—prostate cancer	3.28e-05	0.000273	CcSEcCtD
Nelarabine—Oedema—Prednisone—prostate cancer	3.28e-05	0.000273	CcSEcCtD
Nelarabine—Fatigue—Docetaxel—prostate cancer	3.28e-05	0.000273	CcSEcCtD
Nelarabine—Angiopathy—Epirubicin—prostate cancer	3.28e-05	0.000273	CcSEcCtD
Nelarabine—Urethral disorder—Doxorubicin—prostate cancer	3.28e-05	0.000273	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CREBBP—prostate cancer	3.27e-05	0.000623	CbGpPWpGaD
Nelarabine—Nausea—Mitoxantrone—prostate cancer	3.27e-05	0.000272	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND2—prostate cancer	3.26e-05	0.000621	CbGpPWpGaD
Nelarabine—Infection—Prednisone—prostate cancer	3.26e-05	0.000271	CcSEcCtD
Nelarabine—Mediastinal disorder—Epirubicin—prostate cancer	3.26e-05	0.000271	CcSEcCtD
Nelarabine—Constipation—Docetaxel—prostate cancer	3.25e-05	0.000271	CcSEcCtD
Nelarabine—Pain—Docetaxel—prostate cancer	3.25e-05	0.000271	CcSEcCtD
Nelarabine—Chills—Epirubicin—prostate cancer	3.24e-05	0.00027	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	3.23e-05	0.000615	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTA1—prostate cancer	3.23e-05	0.000615	CbGpPWpGaD
Nelarabine—Nervous system disorder—Prednisone—prostate cancer	3.22e-05	0.000268	CcSEcCtD
Nelarabine—Decreased appetite—Capecitabine—prostate cancer	3.2e-05	0.000267	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTO1—prostate cancer	3.19e-05	0.000608	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD3B2—prostate cancer	3.19e-05	0.000608	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NAT2—prostate cancer	3.19e-05	0.000608	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.18e-05	0.000265	CcSEcCtD
Nelarabine—Fatigue—Capecitabine—prostate cancer	3.18e-05	0.000264	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTA4—prostate cancer	3.17e-05	0.000604	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TBXAS1—prostate cancer	3.17e-05	0.000604	CbGpPWpGaD
Nelarabine—Mental disorder—Epirubicin—prostate cancer	3.16e-05	0.000263	CcSEcCtD
Nelarabine—Constipation—Capecitabine—prostate cancer	3.15e-05	0.000262	CcSEcCtD
Nelarabine—Pain—Capecitabine—prostate cancer	3.15e-05	0.000262	CcSEcCtD
Nelarabine—Malnutrition—Epirubicin—prostate cancer	3.14e-05	0.000262	CcSEcCtD
Nelarabine—Feeling abnormal—Docetaxel—prostate cancer	3.14e-05	0.000261	CcSEcCtD
Nelarabine—Diarrhoea—Etoposide—prostate cancer	3.13e-05	0.000261	CcSEcCtD
Nelarabine—Anorexia—Prednisone—prostate cancer	3.13e-05	0.00026	CcSEcCtD
Nelarabine—Eye disorder—Doxorubicin—prostate cancer	3.12e-05	0.00026	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—CHEK2—prostate cancer	3.11e-05	0.000593	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Docetaxel—prostate cancer	3.11e-05	0.000259	CcSEcCtD
Nelarabine—Cardiac disorder—Doxorubicin—prostate cancer	3.1e-05	0.000258	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CD—prostate cancer	3.1e-05	0.000591	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—MYC—prostate cancer	3.09e-05	0.000588	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTA2—prostate cancer	3.09e-05	0.000588	CbGpPWpGaD
Nelarabine—Dysgeusia—Epirubicin—prostate cancer	3.08e-05	0.000256	CcSEcCtD
Nelarabine—ADA—Metabolism—PLCB2—prostate cancer	3.06e-05	0.000583	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2C18—prostate cancer	3.06e-05	0.000583	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LRP2—prostate cancer	3.06e-05	0.000583	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	3.06e-05	0.000583	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SULT1A1—prostate cancer	3.05e-05	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG5—prostate cancer	3.05e-05	0.000581	CbGpPWpGaD
Nelarabine—Back pain—Epirubicin—prostate cancer	3.04e-05	0.000253	CcSEcCtD
Nelarabine—Feeling abnormal—Capecitabine—prostate cancer	3.04e-05	0.000253	CcSEcCtD
Nelarabine—Angiopathy—Doxorubicin—prostate cancer	3.03e-05	0.000252	CcSEcCtD
Nelarabine—Dizziness—Etoposide—prostate cancer	3.03e-05	0.000252	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—APEX1—prostate cancer	3.02e-05	0.000576	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Capecitabine—prostate cancer	3.01e-05	0.000251	CcSEcCtD
Nelarabine—Mediastinal disorder—Doxorubicin—prostate cancer	3.01e-05	0.000251	CcSEcCtD
Nelarabine—Body temperature increased—Docetaxel—prostate cancer	3.01e-05	0.00025	CcSEcCtD
Nelarabine—Abdominal pain—Docetaxel—prostate cancer	3.01e-05	0.00025	CcSEcCtD
Nelarabine—ADA—Metabolism—P4HB—prostate cancer	3e-05	0.000572	CbGpPWpGaD
Nelarabine—Chills—Doxorubicin—prostate cancer	3e-05	0.00025	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	3e-05	0.000571	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.99e-05	0.000249	CcSEcCtD
Nelarabine—DCK—Metabolism—GSTA1—prostate cancer	2.98e-05	0.000568	CbGpPWpGaD
Nelarabine—Insomnia—Prednisone—prostate cancer	2.97e-05	0.000247	CcSEcCtD
Nelarabine—Vision blurred—Epirubicin—prostate cancer	2.96e-05	0.000247	CcSEcCtD
Nelarabine—DCK—Metabolism—HSD3B2—prostate cancer	2.95e-05	0.000561	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTO1—prostate cancer	2.95e-05	0.000561	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NAT2—prostate cancer	2.95e-05	0.000561	CbGpPWpGaD
Nelarabine—Paraesthesia—Prednisone—prostate cancer	2.95e-05	0.000245	CcSEcCtD
Nelarabine—DGUOK—Metabolism—NOS3—prostate cancer	2.93e-05	0.000558	CbGpPWpGaD
Nelarabine—Mental disorder—Doxorubicin—prostate cancer	2.93e-05	0.000244	CcSEcCtD
Nelarabine—ADA—Metabolism—SLC22A1—prostate cancer	2.92e-05	0.000556	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	2.92e-05	0.000556	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND2—prostate cancer	2.92e-05	0.000555	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—BRCA1—prostate cancer	2.92e-05	0.000555	CbGpPWpGaD
Nelarabine—Body temperature increased—Capecitabine—prostate cancer	2.91e-05	0.000242	CcSEcCtD
Nelarabine—Abdominal pain—Capecitabine—prostate cancer	2.91e-05	0.000242	CcSEcCtD
Nelarabine—Vomiting—Etoposide—prostate cancer	2.91e-05	0.000242	CcSEcCtD
Nelarabine—Malnutrition—Doxorubicin—prostate cancer	2.91e-05	0.000242	CcSEcCtD
Nelarabine—Anaemia—Epirubicin—prostate cancer	2.91e-05	0.000242	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	2.89e-05	0.00055	CbGpPWpGaD
Nelarabine—Headache—Etoposide—prostate cancer	2.87e-05	0.000239	CcSEcCtD
Nelarabine—Decreased appetite—Prednisone—prostate cancer	2.85e-05	0.000237	CcSEcCtD
Nelarabine—Dysgeusia—Doxorubicin—prostate cancer	2.85e-05	0.000237	CcSEcCtD
Nelarabine—ADA—Metabolism—SULT2A1—prostate cancer	2.85e-05	0.000542	CbGpPWpGaD
Nelarabine—Fatigue—Prednisone—prostate cancer	2.83e-05	0.000235	CcSEcCtD
Nelarabine—DCK—Metabolism—PLCB2—prostate cancer	2.83e-05	0.000538	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2C18—prostate cancer	2.83e-05	0.000538	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LRP2—prostate cancer	2.83e-05	0.000538	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	2.82e-05	0.000538	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	2.82e-05	0.000536	CbGpPWpGaD
Nelarabine—Leukopenia—Epirubicin—prostate cancer	2.81e-05	0.000234	CcSEcCtD
Nelarabine—Back pain—Doxorubicin—prostate cancer	2.81e-05	0.000234	CcSEcCtD
Nelarabine—Constipation—Prednisone—prostate cancer	2.81e-05	0.000234	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—TYMS—prostate cancer	2.81e-05	0.000534	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MED12—prostate cancer	2.8e-05	0.000533	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNG5—prostate cancer	2.78e-05	0.000529	CbGpPWpGaD
Nelarabine—DCK—Metabolism—P4HB—prostate cancer	2.77e-05	0.000528	CbGpPWpGaD
Nelarabine—Loss of consciousness—Epirubicin—prostate cancer	2.76e-05	0.00023	CcSEcCtD
Nelarabine—Cough—Epirubicin—prostate cancer	2.74e-05	0.000228	CcSEcCtD
Nelarabine—Vision blurred—Doxorubicin—prostate cancer	2.74e-05	0.000228	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—TP53—prostate cancer	2.73e-05	0.00052	CbGpPWpGaD
Nelarabine—Asthenia—Docetaxel—prostate cancer	2.73e-05	0.000227	CcSEcCtD
Nelarabine—Convulsion—Epirubicin—prostate cancer	2.72e-05	0.000227	CcSEcCtD
Nelarabine—Nausea—Etoposide—prostate cancer	2.72e-05	0.000226	CcSEcCtD
Nelarabine—Feeling abnormal—Prednisone—prostate cancer	2.7e-05	0.000225	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3CB—prostate cancer	2.7e-05	0.000515	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC22A1—prostate cancer	2.7e-05	0.000513	CbGpPWpGaD
Nelarabine—Anaemia—Doxorubicin—prostate cancer	2.69e-05	0.000224	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	2.69e-05	0.000512	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Prednisone—prostate cancer	2.68e-05	0.000223	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—prostate cancer	2.68e-05	0.00051	CbGpPWpGaD
Nelarabine—Arthralgia—Epirubicin—prostate cancer	2.68e-05	0.000223	CcSEcCtD
Nelarabine—Chest pain—Epirubicin—prostate cancer	2.68e-05	0.000223	CcSEcCtD
Nelarabine—Myalgia—Epirubicin—prostate cancer	2.68e-05	0.000223	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOA3—prostate cancer	2.68e-05	0.00051	CbGpPWpGaD
Nelarabine—Asthenia—Capecitabine—prostate cancer	2.64e-05	0.00022	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—BRCA2—prostate cancer	2.64e-05	0.000502	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SULT2A1—prostate cancer	2.63e-05	0.0005	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	2.61e-05	0.000498	CbGpPWpGaD
Nelarabine—Leukopenia—Doxorubicin—prostate cancer	2.6e-05	0.000217	CcSEcCtD
Nelarabine—Diarrhoea—Docetaxel—prostate cancer	2.6e-05	0.000217	CcSEcCtD
Nelarabine—Abdominal pain—Prednisone—prostate cancer	2.59e-05	0.000216	CcSEcCtD
Nelarabine—Body temperature increased—Prednisone—prostate cancer	2.59e-05	0.000216	CcSEcCtD
Nelarabine—Confusional state—Epirubicin—prostate cancer	2.59e-05	0.000215	CcSEcCtD
Nelarabine—DCK—Metabolism—MED12—prostate cancer	2.58e-05	0.000492	CbGpPWpGaD
Nelarabine—Oedema—Epirubicin—prostate cancer	2.57e-05	0.000214	CcSEcCtD
Nelarabine—DCK—Metabolism—GNG5—prostate cancer	2.56e-05	0.000488	CbGpPWpGaD
Nelarabine—Loss of consciousness—Doxorubicin—prostate cancer	2.56e-05	0.000213	CcSEcCtD
Nelarabine—ADA—Metabolism—HPGDS—prostate cancer	2.55e-05	0.000486	CbGpPWpGaD
Nelarabine—Infection—Epirubicin—prostate cancer	2.55e-05	0.000212	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	2.54e-05	0.000485	CbGpPWpGaD
Nelarabine—Cough—Doxorubicin—prostate cancer	2.54e-05	0.000211	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP2C19—prostate cancer	2.54e-05	0.000483	CbGpPWpGaD
Nelarabine—Convulsion—Doxorubicin—prostate cancer	2.52e-05	0.00021	CcSEcCtD
Nelarabine—Diarrhoea—Capecitabine—prostate cancer	2.52e-05	0.00021	CcSEcCtD
Nelarabine—Nervous system disorder—Epirubicin—prostate cancer	2.52e-05	0.000209	CcSEcCtD
Nelarabine—Dizziness—Docetaxel—prostate cancer	2.52e-05	0.000209	CcSEcCtD
Nelarabine—Thrombocytopenia—Epirubicin—prostate cancer	2.51e-05	0.000209	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—TYMS—prostate cancer	2.51e-05	0.000478	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—prostate cancer	2.5e-05	0.000476	CbGpPWpGaD
Nelarabine—Chest pain—Doxorubicin—prostate cancer	2.48e-05	0.000206	CcSEcCtD
Nelarabine—Arthralgia—Doxorubicin—prostate cancer	2.48e-05	0.000206	CcSEcCtD
Nelarabine—Myalgia—Doxorubicin—prostate cancer	2.48e-05	0.000206	CcSEcCtD
Nelarabine—ADA—Metabolism—GSTT1—prostate cancer	2.48e-05	0.000472	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACHE—prostate cancer	2.48e-05	0.000472	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOA3—prostate cancer	2.47e-05	0.00047	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2A6—prostate cancer	2.45e-05	0.000466	CbGpPWpGaD
Nelarabine—Anorexia—Epirubicin—prostate cancer	2.45e-05	0.000204	CcSEcCtD
Nelarabine—Dizziness—Capecitabine—prostate cancer	2.44e-05	0.000203	CcSEcCtD
Nelarabine—Vomiting—Docetaxel—prostate cancer	2.42e-05	0.000201	CcSEcCtD
Nelarabine—Hypotension—Epirubicin—prostate cancer	2.4e-05	0.0002	CcSEcCtD
Nelarabine—Confusional state—Doxorubicin—prostate cancer	2.39e-05	0.000199	CcSEcCtD
Nelarabine—Headache—Docetaxel—prostate cancer	2.38e-05	0.000198	CcSEcCtD
Nelarabine—ADA—Metabolism—AKR1C3—prostate cancer	2.38e-05	0.000454	CbGpPWpGaD
Nelarabine—Oedema—Doxorubicin—prostate cancer	2.37e-05	0.000198	CcSEcCtD
Nelarabine—ADA—Metabolism—PRKACB—prostate cancer	2.37e-05	0.000451	CbGpPWpGaD
Nelarabine—Infection—Doxorubicin—prostate cancer	2.36e-05	0.000196	CcSEcCtD
Nelarabine—DCK—Metabolism—HPGDS—prostate cancer	2.36e-05	0.000449	CbGpPWpGaD
Nelarabine—Asthenia—Prednisone—prostate cancer	2.35e-05	0.000196	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP17A1—prostate cancer	2.34e-05	0.000446	CbGpPWpGaD
Nelarabine—Vomiting—Capecitabine—prostate cancer	2.34e-05	0.000195	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP2C19—prostate cancer	2.34e-05	0.000446	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.34e-05	0.000446	CbGpPWpGaD
Nelarabine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.34e-05	0.000195	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTEN—prostate cancer	2.34e-05	0.000445	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.34e-05	0.000445	CbGpPWpGaD
Nelarabine—Nervous system disorder—Doxorubicin—prostate cancer	2.33e-05	0.000194	CcSEcCtD
Nelarabine—Thrombocytopenia—Doxorubicin—prostate cancer	2.33e-05	0.000194	CcSEcCtD
Nelarabine—Insomnia—Epirubicin—prostate cancer	2.32e-05	0.000193	CcSEcCtD
Nelarabine—Headache—Capecitabine—prostate cancer	2.31e-05	0.000192	CcSEcCtD
Nelarabine—Paraesthesia—Epirubicin—prostate cancer	2.3e-05	0.000192	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.29e-05	0.000436	CbGpPWpGaD
Nelarabine—Dyspnoea—Epirubicin—prostate cancer	2.29e-05	0.00019	CcSEcCtD
Nelarabine—DCK—Metabolism—ACHE—prostate cancer	2.29e-05	0.000435	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTT1—prostate cancer	2.29e-05	0.000435	CbGpPWpGaD
Nelarabine—Somnolence—Epirubicin—prostate cancer	2.28e-05	0.00019	CcSEcCtD
Nelarabine—Anorexia—Doxorubicin—prostate cancer	2.26e-05	0.000188	CcSEcCtD
Nelarabine—Nausea—Docetaxel—prostate cancer	2.26e-05	0.000188	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP2A6—prostate cancer	2.26e-05	0.00043	CbGpPWpGaD
Nelarabine—Diarrhoea—Prednisone—prostate cancer	2.25e-05	0.000187	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOA2—prostate cancer	2.23e-05	0.000425	CbGpPWpGaD
Nelarabine—Decreased appetite—Epirubicin—prostate cancer	2.23e-05	0.000186	CcSEcCtD
Nelarabine—DGUOK—Metabolism—EP300—prostate cancer	2.23e-05	0.000424	CbGpPWpGaD
Nelarabine—Hypotension—Doxorubicin—prostate cancer	2.22e-05	0.000185	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.22e-05	0.000184	CcSEcCtD
Nelarabine—Fatigue—Epirubicin—prostate cancer	2.21e-05	0.000184	CcSEcCtD
Nelarabine—DCK—Metabolism—AKR1C3—prostate cancer	2.2e-05	0.000419	CbGpPWpGaD
Nelarabine—Pain—Epirubicin—prostate cancer	2.19e-05	0.000183	CcSEcCtD
Nelarabine—Constipation—Epirubicin—prostate cancer	2.19e-05	0.000183	CcSEcCtD
Nelarabine—Nausea—Capecitabine—prostate cancer	2.19e-05	0.000182	CcSEcCtD
Nelarabine—DCK—Metabolism—PRKACB—prostate cancer	2.19e-05	0.000416	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TERT—prostate cancer	2.19e-05	0.000416	CbGpPWpGaD
Nelarabine—Dizziness—Prednisone—prostate cancer	2.17e-05	0.000181	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.16e-05	0.00018	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP17A1—prostate cancer	2.16e-05	0.000412	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.16e-05	0.000412	CbGpPWpGaD
Nelarabine—Insomnia—Doxorubicin—prostate cancer	2.15e-05	0.000179	CcSEcCtD
Nelarabine—Paraesthesia—Doxorubicin—prostate cancer	2.13e-05	0.000177	CcSEcCtD
Nelarabine—ADA—Metabolism—SLC5A5—prostate cancer	2.13e-05	0.000406	CbGpPWpGaD
Nelarabine—Dyspnoea—Doxorubicin—prostate cancer	2.12e-05	0.000176	CcSEcCtD
Nelarabine—Feeling abnormal—Epirubicin—prostate cancer	2.11e-05	0.000176	CcSEcCtD
Nelarabine—Somnolence—Doxorubicin—prostate cancer	2.11e-05	0.000176	CcSEcCtD
Nelarabine—Gastrointestinal pain—Epirubicin—prostate cancer	2.1e-05	0.000175	CcSEcCtD
Nelarabine—Vomiting—Prednisone—prostate cancer	2.09e-05	0.000174	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP2E1—prostate cancer	2.08e-05	0.000396	CbGpPWpGaD
Nelarabine—Decreased appetite—Doxorubicin—prostate cancer	2.06e-05	0.000172	CcSEcCtD
Nelarabine—DCK—Metabolism—NCOA2—prostate cancer	2.06e-05	0.000393	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NQO1—prostate cancer	2.06e-05	0.000392	CbGpPWpGaD
Nelarabine—Headache—Prednisone—prostate cancer	2.06e-05	0.000171	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.05e-05	0.000171	CcSEcCtD
Nelarabine—Fatigue—Doxorubicin—prostate cancer	2.05e-05	0.00017	CcSEcCtD
Nelarabine—Pain—Doxorubicin—prostate cancer	2.03e-05	0.000169	CcSEcCtD
Nelarabine—Constipation—Doxorubicin—prostate cancer	2.03e-05	0.000169	CcSEcCtD
Nelarabine—Abdominal pain—Epirubicin—prostate cancer	2.03e-05	0.000169	CcSEcCtD
Nelarabine—Body temperature increased—Epirubicin—prostate cancer	2.03e-05	0.000169	CcSEcCtD
Nelarabine—ADA—Metabolism—TH—prostate cancer	2.03e-05	0.000386	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP3A4—prostate cancer	2.01e-05	0.000382	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.99e-05	0.000378	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP1B1—prostate cancer	1.97e-05	0.000376	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC5A5—prostate cancer	1.97e-05	0.000375	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—ATM—prostate cancer	1.96e-05	0.000374	CbGpPWpGaD
Nelarabine—Feeling abnormal—Doxorubicin—prostate cancer	1.96e-05	0.000163	CcSEcCtD
Nelarabine—Nausea—Prednisone—prostate cancer	1.95e-05	0.000162	CcSEcCtD
Nelarabine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.94e-05	0.000162	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.92e-05	0.000366	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2E1—prostate cancer	1.92e-05	0.000366	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GGT1—prostate cancer	1.91e-05	0.000364	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NQO1—prostate cancer	1.9e-05	0.000362	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NCOA1—prostate cancer	1.88e-05	0.000358	CbGpPWpGaD
Nelarabine—Body temperature increased—Doxorubicin—prostate cancer	1.88e-05	0.000156	CcSEcCtD
Nelarabine—Abdominal pain—Doxorubicin—prostate cancer	1.88e-05	0.000156	CcSEcCtD
Nelarabine—DCK—Metabolism—TH—prostate cancer	1.87e-05	0.000357	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP19A1—prostate cancer	1.86e-05	0.000353	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP3A4—prostate cancer	1.85e-05	0.000353	CbGpPWpGaD
Nelarabine—Asthenia—Epirubicin—prostate cancer	1.84e-05	0.000153	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP1B1—prostate cancer	1.82e-05	0.000347	CbGpPWpGaD
Nelarabine—ADA—Metabolism—RXRA—prostate cancer	1.79e-05	0.000341	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GGT1—prostate cancer	1.76e-05	0.000336	CbGpPWpGaD
Nelarabine—Diarrhoea—Epirubicin—prostate cancer	1.76e-05	0.000146	CcSEcCtD
Nelarabine—DCK—Metabolism—NCOA1—prostate cancer	1.74e-05	0.000331	CbGpPWpGaD
Nelarabine—ADA—Metabolism—COMT—prostate cancer	1.72e-05	0.000328	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTP1—prostate cancer	1.72e-05	0.000327	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP19A1—prostate cancer	1.71e-05	0.000326	CbGpPWpGaD
Nelarabine—Asthenia—Doxorubicin—prostate cancer	1.7e-05	0.000142	CcSEcCtD
Nelarabine—Dizziness—Epirubicin—prostate cancer	1.7e-05	0.000141	CcSEcCtD
Nelarabine—ADA—Metabolism—ITPR1—prostate cancer	1.69e-05	0.000322	CbGpPWpGaD
Nelarabine—DCK—Metabolism—RXRA—prostate cancer	1.65e-05	0.000315	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PIK3CA—prostate cancer	1.65e-05	0.000314	CbGpPWpGaD
Nelarabine—Vomiting—Epirubicin—prostate cancer	1.63e-05	0.000136	CcSEcCtD
Nelarabine—Diarrhoea—Doxorubicin—prostate cancer	1.62e-05	0.000135	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.62e-05	0.000309	CbGpPWpGaD
Nelarabine—Headache—Epirubicin—prostate cancer	1.61e-05	0.000134	CcSEcCtD
Nelarabine—ADA—Metabolism—TYMS—prostate cancer	1.6e-05	0.000304	CbGpPWpGaD
Nelarabine—DCK—Metabolism—COMT—prostate cancer	1.59e-05	0.000303	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTP1—prostate cancer	1.58e-05	0.000302	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—prostate cancer	1.58e-05	0.0003	CbGpPWpGaD
Nelarabine—Dizziness—Doxorubicin—prostate cancer	1.57e-05	0.000131	CcSEcCtD
Nelarabine—DCK—Metabolism—ITPR1—prostate cancer	1.56e-05	0.000297	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPL—prostate cancer	1.55e-05	0.000295	CbGpPWpGaD
Nelarabine—Nausea—Epirubicin—prostate cancer	1.52e-05	0.000127	CcSEcCtD
Nelarabine—Vomiting—Doxorubicin—prostate cancer	1.51e-05	0.000126	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP1A1—prostate cancer	1.5e-05	0.000285	CbGpPWpGaD
Nelarabine—Headache—Doxorubicin—prostate cancer	1.49e-05	0.000124	CcSEcCtD
Nelarabine—ADA—Metabolism—ERCC2—prostate cancer	1.48e-05	0.000282	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—prostate cancer	1.48e-05	0.000282	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TYMS—prostate cancer	1.47e-05	0.00028	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—prostate cancer	1.46e-05	0.000277	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MDM2—prostate cancer	1.45e-05	0.000276	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPL—prostate cancer	1.43e-05	0.000272	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND1—prostate cancer	1.41e-05	0.000269	CbGpPWpGaD
Nelarabine—Nausea—Doxorubicin—prostate cancer	1.41e-05	0.000117	CcSEcCtD
Nelarabine—ADA—Metabolism—MTHFR—prostate cancer	1.39e-05	0.000265	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1A1—prostate cancer	1.38e-05	0.000263	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ERCC2—prostate cancer	1.37e-05	0.000261	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARA—prostate cancer	1.37e-05	0.00026	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—prostate cancer	1.37e-05	0.00026	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—prostate cancer	1.35e-05	0.000256	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1B—prostate cancer	1.32e-05	0.000252	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—EP300—prostate cancer	1.3e-05	0.000248	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—prostate cancer	1.29e-05	0.000245	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAV1—prostate cancer	1.29e-05	0.000245	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND1—prostate cancer	1.26e-05	0.000241	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARA—prostate cancer	1.26e-05	0.00024	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN1A—prostate cancer	1.22e-05	0.000233	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAV1—prostate cancer	1.19e-05	0.000226	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CG—prostate cancer	1.17e-05	0.000223	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—EP300—prostate cancer	1.16e-05	0.000221	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—MYC—prostate cancer	1.13e-05	0.000216	CbGpPWpGaD
Nelarabine—ADA—Metabolism—INS—prostate cancer	1.11e-05	0.000211	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CREBBP—prostate cancer	1.09e-05	0.000207	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CG—prostate cancer	1.08e-05	0.000206	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CD—prostate cancer	1.03e-05	0.000196	CbGpPWpGaD
Nelarabine—DCK—Metabolism—INS—prostate cancer	1.02e-05	0.000195	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—MYC—prostate cancer	1.01e-05	0.000193	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CREBBP—prostate cancer	1e-05	0.000191	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NOS3—prostate cancer	9.72e-06	0.000185	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CD—prostate cancer	9.5e-06	0.000181	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CB—prostate cancer	8.97e-06	0.000171	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NOS3—prostate cancer	8.97e-06	0.000171	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—prostate cancer	8.89e-06	0.000169	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—TP53—prostate cancer	8.32e-06	0.000158	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CB—prostate cancer	8.28e-06	0.000158	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—prostate cancer	8.21e-06	0.000156	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTEN—prostate cancer	7.76e-06	0.000148	CbGpPWpGaD
Nelarabine—ADA—Metabolism—EP300—prostate cancer	7.4e-06	0.000141	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTEN—prostate cancer	7.16e-06	0.000136	CbGpPWpGaD
Nelarabine—DCK—Metabolism—EP300—prostate cancer	6.83e-06	0.00013	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3CA—prostate cancer	5.47e-06	0.000104	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3CA—prostate cancer	5.05e-06	9.62e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—prostate cancer	4.47e-06	8.51e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—prostate cancer	4.12e-06	7.86e-05	CbGpPWpGaD
